ZURCHER KANTONALBANK FINANCE (GUERNSEY) LIMITED | Market Closed - Bid/Ask 11:20:00 2024-07-10 am EDT | After market 11:15:00 am | |||
| 78.53 CHF | +2.59% |
|
78.62 | +0.11% |
| 3 months | -10.39% | ||
| 6 months | -12.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-07-10 | 78.53 | +2.59% |
Delayed Quote Swiss Exchange
Last update July 10, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Certificats Divers |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | ZKB |
| Z08BIZ | |
| ISIN | CH1273465778 |
| Date issued | 2023-10-02 |
| Maturity | 2026-09-28 (808 Days) |
| Parity | 1 : 1 |
| Emission price | 100 CHF |
| Emission volume | N/A |
| Settlement | les deux |
| Currency | CHF |
Technical Indicators
| Highest since issue | 99.9 CHF |
|---|---|
| Lowest since issue | 72.65 CHF |
| Spread | 7 CHF |
| Spread % | 0.89% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.75
USD
Average target price
52.74
USD
Spread / Average Target
+29.42%
- Stock Market
- Certificates
- Z08BIZ Certificat
